Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999

Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999–2004)

Published:2007-05 Issue:1 Volume:58 Page:19-26
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Fritsche Thomas R.,Sader Helio S.,Jones Ronald N.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference39 articles.

1. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model;Andes;Antimicrob. Agents Chemother.,2003

2. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997–2001);Andrade;J. Antimicrob. Chemother.,2003

3. Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects;Andrews;J. Antimicrob. Chemother.,2003

4. Sequential IV to PO garenoxacin vs. IV ampicillin/sulbactam to amoxicillin/clavulanate to treat serious acute pelvic infection;Ariza,2005

5. Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003;Buck;Emerg. Infect. Dis.,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis;Expert Opinion on Pharmacotherapy;2020-01-31

2. S2k guidelines for skin and soft tissue infections Excerpts from the S2k guidelines for “calculated initial parenteral treatment of bacterial infections in adults – update 2018“;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2019-03

3. S2k‐Leitlinie Haut‐ und WeichgewebeinfektionenAuszug aus „Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2018“;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2019-03

4. Endophthalmitis Caused by Methicillin-Resistant Staphylococcus aureus (MRSA);Endophthalmitis;2017-08-12

5. Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures;Journal of Chromatography B;2016-09